Pfizer Will Examine Genizon Genomic Data For Biomarkers
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm will use the collaboration as a discovery platform for biomarkers for Alzheimer's disease, ADHD and endometriosis.